Gene · 114907
Papers2,920
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,920
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Dysregulation of the ubiquitin-proteasome system in aging skeletal muscle. | Biomed Pharmacother | 2026 | 42119273 | PubTator, text mining | PubMed |
| Selective activation of the unfolded protein response and proteolytic pathways in sarcopenic limb muscles of bronchiectasis patients. | ERJ Open Res | 2026 | 42111389 | PubTator, text mining | PubMed |
| Deubiquitinase YOD1 Inhibition Suppresses DEX- and Denervation-Induced Muscle Atrophy Through MAFbx Destabilization. | J Cachexia Sarcopenia Muscle | 2026 | 42052961 | PubTator, text mining | PubMed |
| Inflammation-Linked Muscle Atrophy in Limb Girdle Muscular Dystrophy R1 (LGMDR1): Insights into Disease Mechanisms. | Curr Issues Mol Biol | 2026 | 42042021 | PubTator, text mining | PubMed |
| Exosomes Derived From Mesenchymal Stem Cells Regulating Myotube Cell Atrophy via NF-κB Signaling Pathway. | Stem Cells Int | 2026 | 42027319 | PubTator, text mining | PubMed |
| Integrated miRNA-mRNA Analysis Reveals Obesity-Driven Regulatory Networks in Human Visceral Adipose Tissue With and Without Type 2 Diabetes. | Diabetes Obes Metab | 2026 | 42023419 | PubTator, text mining | PubMed |
| In silico virtual knockout identifies PXDNL as a fibroblast-specific driver of sarcopenia and GABA as a potential modulator. | Biochem Biophys Res Commun | 2026 | 41996735 | PubTator, text mining | PubMed |
| From Initiation to Elongation: eIF3 as a Dual-Phase Guardian of Mitochondrial Integrity and Protein Homeostasis in Skeletal Muscle. | FASEB J | 2026 | 41989318 | PubTator, text mining | PubMed |
| MCC950-Loaded M12-Liposome Nanoparticles for Targeted Inhibition of NLRP3 Inflammasome in Sepsis-Induced Muscle Atrophy. | J Cachexia Sarcopenia Muscle | 2026 | 41983452 | PubTator, text mining | PubMed |
| Correction: METTL3/YTHDF1 drives M1 macrophage polarization and aggravates ulcerative colitis progression by regulating m6A modification of SerpinB5 mRNA and FBXO32-dependent NF-κB pathway. | J Gastroenterol | 2026 | 41961123 | PubTator, text mining | PubMed |
| [The management of glucocorticoid-induced myopathy]. | Rev Med Interne | 2026 | 41951495 | PubTator, text mining | PubMed |
| Skeletal Muscle and Circulating microRNAs Adaptations to 12-Week HIIT With or Without L-Citrulline in Obese Older Adults. | J Cachexia Sarcopenia Muscle | 2026 | 41933456 | PubTator, text mining | PubMed |
| Fibro-Adipogenic Progenitors Regulate Orofacial Neuromuscular Junction Regeneration via Myostatin. | J Cachexia Sarcopenia Muscle | 2026 | 41923284 | PubTator, text mining | PubMed |
| Metabolomic Profiles Associated With Difference in Muscle Protein Degradation Between Fast- and Slow-Growing Chicks During the Neonatal Period. | Anim Sci J | 2026 | 41914922 | PubTator, text mining | PubMed |
| Recombinant Human KAI1/CD82 Attenuates Glucocorticoid-Induced Muscle Atrophy by Promoting Myogenic Differentiation. | Int J Mol Sci | 2026 | 41898419 | PubTator, text mining | PubMed |
| Ageing, Sex Differences, and REDs Risk in Endurance Runners: An Integrated Cross-Sectional Study Protocol. | Sports (Basel) | 2026 | 41893612 | PubTator, text mining | PubMed |
| Polystyrene microplastics induce skeletal muscle atrophy through disruption of anabolic signaling and mitochondrial function. | Toxicology | 2026 | 41865969 | PubTator, text mining | PubMed |
| Hot melt extruded Kyungohkgo attenuates skeletal muscle atrophy by downregulating the FOXO3a/MuRF-1/atrogin-1 axis. | Sci Rep | 2026 | 41857090 | PubTator, text mining | PubMed |
| Tumor-muscle communication in cancer-associated cachexia (Review). | Oncol Lett | 2026 | 41852896 | PubTator, text mining | PubMed |
| 0.33g mitigates muscle atrophy while 0.67g preserves muscle function and myofiber type composition in mice during spaceflight. | Sci Adv | 2026 | 41824581 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/114907/papers?page=2